Medical Journal

Index of Articles by Issue 2002 to Present

Issues Quick Links
	Spring 2009 Winter 2008-2009 Autumn 2008 Summer 2008 Spring 2008 Winter 2007 Autumn 2007 Summer 2007 Spring 2007 Winter 2006 Autumn 2006 Summer 2006 Spring 2006 Winter 2005 Autumn 2005 Summer 2005 Spring 2005 Winter 2004 Autumn 2004 Summer 2004 Spring 2004 Winter 2003 Autumn 2003 Summer 2003 Spring 2003 Winter 2002 Autumn 2002 Spring 2002

Search Index by using your Internet browser's "Find on this Page" function under the "Edit" drop-down menu

Edition	Vol.	No.	Topic/Title	Sub-Topics	Author(s)	Pages	Guest Editor(s)
Spring 2002
Spring 2002	1	1	A New Classification of Pulmonary Hypertension		Stuart Rich, MD	3-6
Spring 2002	1	1	Endothelin Receptor Antagonism: A New Era in the Treatment of Pulmonary Arterial Hypertension		Richard N. Channick, MD; Lewis J. Rubin, MD	13-15
Spring 2002	1	1	Roundtable Discussion -- Inside the New Era in Treatment: Three Experts Analyze the Growing Spectrum of Therapy and Future Strategies		Lewis J. Rubin, MD (moderator); Robyn J. Barst, MD; Nazzareno Galie, MD	17-23 (article begins on back cover)
Spring 2002	1	1	Profiles in PH Celebrating the Illustrious Career of Alfred P. Fishman, MD: Founder of the Registry in Pulmonary Hypertension			2, 8
Spring 2002	1	1	Pull-Out Clinical Algorithm Diagnosis of Pulmonary Hypertension
Spring 2002	1	1	Pull-Out Clinical Algorithm Treatment of Pulmonary Hypertension
Autumn 2002
Autumn 2002	1	2	Scleroderma-Associated Pulmonary Hypertension: Who's at Risk and Why		Karen A Fagan, MD; David H. Collier, MD; and David B. Badesch, MD	5-9
Autumn 2002	1	2	Cardiac Catheterization in Pulmonary Arterial Hypertension: A Guide to Proper Use		Ronald J. Oudiz, MD	15-21
Autumn 2002	1	2	Roundtable Discussion -- Screening for PAH in Scleroderma: Identifying Hallmarks of the Disease and Optimal Treatment Strategies		Vallerie V. McLaughlin, MD (moderator); James R. Seibold, MD; David B. Badesch, MD; Virginia Steen, MD	22-25 (article begins on back cover)
Autumn 2002	1	2	Profiles in PH Driven to Find Cure for PH, Brundage Leads New Quest For Breakthrough in Therapy			3, 20
Autumn 2002	1	2	Pull-Out Clinical Algorithm Pulmonary Diagnostic Algorithm for Patients with Scleroderma
Winter 2002
Winter 2002	1	3	Continuous Intravenous Epoprostenol for Pulmonary Arterial Hypertension: Highlighting Practical Issues, Special Considerations		Cathy J. Severson, RN, BSN; Michael D. McGoon, MD	4-8
Winter 2002	1	3	Oral and Subcutaneous Prostacyclin Analogs: Analyzing the Latest Evidence on Efficacy and Safety		Vallerie V. McLaughlin, MD	11-15
Winter 2002	1	3	Inhaled Iloprost for Treatment of Pulmonary Arterial Hypertension		Horst Olschewski, MD	16-21
Winter 2002	1	3	Roundtable Discussion -- Bench to Bedside: Principles and Practice of Epoprostenol Therapy, from Maximizing Benefit to Minimizing Side Effects		Ivan Robbins, MD (moderator); David Langleben, MD; Michael McGoon, MD; Abby Krichman, RRT	22-25
Winter 2002	1	3	Profiles in PH A Nobel Prize Winner Who Triggered a Revolution in Therapy: Sir John Vane			3, 20
Winter 2002	1	3	Pull-Out Clinical Algorithm Elective Initiation of Epoprostenol
Spring 2003	2	1	Chronic Thromboembolic Pulmonary Hypertension			(Topic of Spring 2003 journal)
Spring 2003	2	1	Chronic Thromboembolic Pulmonary Hypertension: When to Suspect It, When to Refer to Surgery		Kim M. Kerr, MD; Peter F. Fedullo, MD; William R. Auger, MD	4-8
Spring 2003	2	1	An Insider's Guide to Pulmonary Thromboendarterectomy: Proven Techniques to Achieve Optimal Results		Michael M. Madani, MD; Stuart W. Jamieson, MB, FRCS	13-20
Spring 2003	2	1	Roundtable Discussion -- Surgically Curable Pulmonary Hypertension: A View From the Experts		Victor F. Tapson, MD (moderator); William Auger, MD; Peter Fedullo, MD; Eckhard Mayer, MD; Christopher McGregor, MD	21-25
Spring 2003	2	1	Profiles in PH The Legacy of Ken Moser Lives on at UCSD			3
Spring 2003	2	1	Pull-Out Clinical Algorithm Evaluation of Chronic Thromboembolic Pulmonary Hypertension
Summer 2003
Summer 2003	2	2	Pulmonary Hypertension in Children: New Insights Offer Opportunity to Reverse the Disease Process		Sheila G. Haworth	4-10
Summer 2003	2	2	Eisenmenger Syndrome in Adults: Strategies to Correct Congential Defects Before Fixed Vascular Disease Develops		Erika Berman Rosenzweig, MD	13-19
Summer 2003	2	2	Roundtable Discussion -- Pulmonary Arterial Hypertension in Congenital Heart Disease: Controversies and Consensus		Robyn J. Barst, MD (moderator); David Wessel, MD; Nancy Bridges, MD; Dunbar Ivy, MD	20-25
Summer 2003	2	2	Profiles in PH Remembering Paul Wood: Relentlessly Driven, Dazzling Diagnostician			3, 10
Summer 2003	2	2	Pull-Out Clinical Algorithm Evaluation of Pulmonary Hypertension in Children
Autumn 2003
Autumn 2003	2	3	NIH Conference Charts Future Directions in Identifying Patients at Risk for Primary Pulmonary Hypertension			4-5
Autumn 2003	2	3	Recapping Highlights from the Third World Symposium on Pulmonary Arterial Hypertension, Venice Italy, June 23-25, 2003			6-7
Autumn 2003	2	3	Task Force on Diagnosis and Assessment: Identifying the Most Useful Tools		Robyn J. Barst, MD	13-14
Autumn 2003	2	3	Overview of Genetics as presented at the PAH Symposium in Venice		C. Gregory Elliott, MD	14
Autumn 2003	2	3	Pathophysiology of Pulmonary Hypertension: Recognizing Triggers of the Disease		Marc Humbert, MD, PhD	15
Autumn 2003	2	3	Report from the Task Force on Medical Treatments		Nazzareno Galie, MD; Alessandra Manes, MD	16
Autumn 2003	2	3	Acute Vasodilator Testing in PAH		Olivier Sitbon, MD	17
Autumn 2003	2	3	Transplantation and Thromboendarterectomy for Severe Pulmonary Hypertension: Report from the Transplant and Interventions Task Force		Paul A. Corris, MB, FRCP	19-20
Autumn 2003	2	3	One-on-One Interview Seeking a Consensus on PH: Challenges Left by the Venice Symposium		Victor F. Tapson, MD (interviewer); Nazzareno Galie, MD	22-23
Autumn 2003	2	3	Profiles in PH Cardiologist Nazzareno Galie: A Guiding Light for Worldwide Consensus on Pulmonary Hypertension			3, 21
Autumn 2003	2	3	Pull-Out Clinical Algorithm Diagnosis and Assesment of Pulmonary Hypertension
Winter 2003	2	4	Future Directions and Emerging Concepts in Pulmonary Hypertension			(Topic of Winter 2003 journal)	Sean Gaine, MD; Richard Channick, MD
Winter 2003	2	4	Sever Angioproliferative Pulmonary Hypertension: The Lung Circulation Between Vasoconstriction and Cancer		Norbert F. Voelkel, MD; Laima Taraseviciene-Steward; Carlyne Cool, MD	4-8
Winter 2003	2	4	What's on the Horizon in Therapy, From Current Approaches to Experimental Agents		Richard N. Channick, MD	9-16
Winter 2003	2	4	New Directions in Pulmonary Hypertension: Expanding the Spectrum of End Points to Enhance Clinical Evaluation		Andrew Peacock, MD	17-20 (references continue onto page 27)
Winter 2003	2	4	Roundtable Discussion -- Future Directions: An Expert Panel Explore the Challenge of Halting Progression and Reversing the Pathology of PAH		Sean Gaine, MD (moderator); Nicholas W. Morrell, MD; Stuart Rich, MD; Norbert Voelkel, MD	22-27
Winter 2003	2	4	Profiles in PH In the Pantheon of PH Research, Tim Higgebottom Sets the Pace			3, 8
Winter 2003	2	4	Pull-Out Clinical Algorithm Trigger Factors Leading to Death of Vascular Edothelial Cells
Spring 2004	3	1	A Complete Guide to Lung Transplantation			(Topic of Spring 2004 journal)	Ronald Oudiz, MD
Spring 2004	3	1	Listing the Patient: Deciding When Transplantation is the Only Viable Life-Sustaining Option		Jonathan B. Orens, MD	4-8
Spring 2004	3	1	Lung Transplantation: Timing, Preoperative Consideratings and Postoperative Outcome		Edward Cantu III, MD; R. Duane David, Jr, MD	9-18
Spring 2004	3	1	Roundtable Discussion -- Protocols in Heart and Lung Transplantation: An Essential Guide to Perioperative Assessment and Timing to Improve Outcomes		Victor Tapson, MD (moderator); Robert Frantz, MD; John Conte, MD	20-25
Spring 2004	3	1	Profiles in PH Joel D. Cooper, MD, the Physician Who Launched Lung Transplantation on Its Path to Successful Outcomes			3, 25
Spring 2004	3	1	Pull-Out Clinical Algorithm Lung Transplant Evaluation: Requirements Prior to Listing
Summer 2004	3	2	Portopulmonary Hypertension			(Topic of Summer 2004 journal)
Summer 2004	3	2	Portopulmonary Hypertension: Understanding Pulmonary Hypertension in the Setting of Liver Disease		Michael J. Krowka, MD	4-8
Summer 2004	3	2	Liver Transplant Considerations and Outcomes for the Portopulmonary Hypertension Patient		Michael Ramsay, MD, FRCA	9-18
Summer 2004	3	2	Roundtable Discussion: Exploring the Spectrum of Pathology and Treatment in Portopulmonary Hypertension: Four Experts Address the Toughest Questions		Ronald J. Oudiz (moderator), MD; Michael J. Krowka, MD; Russell Wiesner, MD; Michael Ramsey, MD, FRCA	20-25
Summer 2004	3	2	Profiles in PH Michael D. McGoon, MD: Guiding Light for PHA Scientific Leadership Council and Propenent of New Research			3, 25
Summer 2004	3	2	Pull-Out Clinical Algorithm Screening and Diagnostic Algorithm for Portopulmonary Hypertension
Summer 2004	3	2	Pull-Out Clinical Algorithm Decision Tree: Management of Pulmonary Hypertension Diagnosed at Induction of Anesthesia for Liver Transplantation
Autumn 2004	3	3	Mechanisms of PH: the Next Therapeutic Targets (Highlights from the Scientific Sessions of the 6th PHA International Conference)	Plus: Medical Treatment Options and Advances in Portopulmonary Hypertension		(Topic of Autumn 2004 journal)	Michael McGoon, MD
Autumn 2004	3	3	Exploring the Role of BMPR2 as Key Genetic Marker in Pulmonary Vascular Disease		Joseph Loscalzo, MD, PhD	4-5
Autumn 2004	3	3	Why Potassium Channel Dysfunction May Be 'Missing Link' in Pathophysiology of PAH		Evangelos D. Michelakis, MD; Stephen L. Archer, MD	6-16
Autumn 2004	3	3	Medical Treatment Options/Advances in Portopulmonary Hypertension: How the Spectrum is Expanding		Raymond L. Benza, MD	17-22
Autumn 2004	3	3	Roundtable Discussion -- Recapping Highlights from Pulmonary Hypertension Association Scientific Sessions and Identifying Key Issues Driving Translational Research		Michael McGoon, MD (moderator); Victor F. Tapson, MD; Richard N. Channic, MD; Vallerie V. McLaughlin, MD; Ronald J. Oudiz, MD; Ivan M. Robbins, MD	23-27
Autumn 2004	3	3	Profiles in PH Juggling Roles of Patient Advocate and Director of a Leading Research Center, Robyn Barst Meets the Challenge		3, 16
Winter 2004	3	4	Pulmonary Hypertension Experts Analyze the New ACCP Evidence-Based Clinical Practice Guidelines	Pulmonary Arterial Hypertension: Diagnostic Considerations -and- Pulmonary Arterial Hypertension: Therapeutic Considerations		(Topic of Winter 2004 journal)
Winter 2004	3	4	Pulmonary Arterial Hypertension: Diagnostic Considerations			(Sub-topic of Winter 2004 journal)
Winter 2004	3	4	Echocardiography		Alan L. Hinderliter, MD	4-5
Winter 2004	3	4	The Role of Electrocardiography		Gregory S. Ahearn, MD	5-6
Winter 2004	3	4	Implantable Hemodynamic Monitoring		Raymond L. Benza, MD	6-8
Winter 2004	3	4	Cardiopulmonary Exercise Testing		Ronald J. Oudiz, MD	8
Winter 2004	3	4	Pulmonary Arterial Hypertension: Therapeutic Considerations			(Sub-topic of Winter 2004 journal)
Winter 2004	3	4	Calcium-Channel Blockers		Sean Gaine, MD, PhD	8-9
Winter 2004	3	4	Treating Class II PAH Patients		Robert Schilz, DO, PhD	9-10
Winter 2004	3	4	Treating Class III PAH Patients		Nicholas Hill, MD; Iona Preston, MD	10-14
Winter 2004	3	4	Treating Class IV PAH Patients		James R. Klinger, MD	14-15
Winter 2004	3	4	Considering Sildenafil		James R. Gossage, MD	15
Winter 2004	3	4	Relative Merits of Different Endothelin Antagonists		Richard Channick, MD	16
Winter 2004	3	4	Discontinuing Epoprostenol		Adaani Frost, MD	16-17
Winter 2004	3	4	When to Use Treprostinil		Robert C. Bourge, MD	17
Winter 2004	3	4	PAH Treatment in Germany		Horst Olschewski, MD	17-18
Winter 2004	3	4	Combination Therapy		Karen Fagan, MD	18
Winter 2004	3	4	Treatment Options in Portopulmonary Hypertension		Roxana Sulica, MD; Louis R. DePalo, MD	18-22
Winter 2004	3	4	Severe PH Associated with LVDD		Melvyn Rubenfire, MD	22-23
Winter 2004	3	4	Profiles in PH From ACCP Guidelines to Pharmacogenomics of PH, Lewis Rubin, MD, Stands Tall as a Prime Mover			3, 25
Spring 2005	4	1	The Genetic Factor in PAH: New Findings, Future Directions			(Topic of Spring 2005 journal)	Ivan Robbins, MD
Spring 2005	4	1	Defining the Role and Clinical Relevance of BMPR2 Mutations In Pulmonary Arterial Hypertension		Jane H. Morse, MD	5-12
Spring 2005	4	1	TGF-beta Receptors in Pulmonary Arterial Hypertension: The HHT Connection		Richard C. Trembath, MD	13-16
Spring 2005	4	1	The Serotonin Pathway in Pulmonary Hypertension		Saadia Eddahibi, PhD; Serge Adnot, MD	20-23
Spring 2005	4	1	Potential Genetic Contributions to Nonidiopathic, Nonfamilial Pulmonary Hypertension		Karen A. Fagan, MD	24-28
Spring 2005	4	1	The Future of Genetics in Pulmonary Arterial Hypertension		John H. Newman, MD	30-31
Spring 2005	4	1	Profiles in PH Probing Early Mysterious Deaths in Families, Jim Loyd, MD, Helps Solve Riddle of Genetic Mutation in PPH			4, 12
Summer 2005
Summer 2005	4	2	Pulmonary Hypertension Due to Respiratory Disease: Pathogenesis and Diagnostic Approach		Reda E. Girgis, MB, BCh	5-11	Richard Channick, MD
Summer 2005	4	2	The New UNOS Lung Transplantation Allocation System		Gundeep S. Dhillon, MD; Ramona L. Doyle, MD	12-13
Summer 2005	4	2	Treatment of Pulmonary Hypertension Related to Disorders of Hypoxia		Robert Schilz, DO, PhD	14-22
Summer 2005	4	2	Roundtable Discussion -- Pulmonary Hypertension in Lung/Respiratory Disease: How Important? What to Do?		Richard Channick (moderator), MD; Hap Farber, MD; Nicholas Hill, MD; Robert Schilz, PhD, DO	24-29
Summer 2005	4	2	Profiles in PH Climbing with Dr. John West in the Rarefied Air of Pulmonary Research: From Mount Everest to the University of California, San Diego			4, 11
Autumn 2005	4	3	Essential Guide to Diagnosing PAH			(Topic of Autumn 2005 journal)
Autumn 2005	4	3	Physical Examination in Pulmonary Arterial Hypertension		Todd M. Bull, MD	6-10
Autumn 2005	4	3	Initial Diagnostic Testing in the Evaluation of Pulmonary Hypertension		Terence K. Trow, MD	11-14
Autumn 2005	4	3	Cardiac Catheterization in Pulmonary Arterial Hypertension: An Updated Guide to Proper Use		Ronald J. Oudiz, MD; David Langleben, MD	15-25
Autumn 2005	4	3	Roundtable Discussion -- Integrating Current Strategies for Continuing Assessment of Pulmonary Arterial Hypertension		Vallerie V. McLaughlin, MD (moderator); Richard N. Channick, MD; Ivan M. Robbins, MD; Victor F. Tapson, MD	26-30
Autumn 2005	4	3	Profiles in PH Never Wavering from a Long Commitment to a Cure for PH, Stuart Rich, MD, Aims to Stop the Disease in Its Tracks			4
Winter 2005	4	4	Pulmonary Hypertension in the Critical Care Setting			(Topic of Winter 2005 journal)	Roxana Sulica, MD; Ramona L. Doyle, MD
Winter 2005	4	4	Perioperative Management of PH: Covering All Aspects From Risk Assessment to Postoperative Considerations		Ronald G. Pearl, PhD, MD	6-15
Winter 2005	4	4	Managing Right Ventricular Failure in PAH: An Algorithmic Approach		Teresa De Marco, MD; Dana McGlothin, MD	16-26
Winter 2005	4	4	Cases from the Pulmonary Hypertension Service		Roxana Sulica, MD: Ramona Doyle, MD	27-30
Winter 2005	4	4	Roundtable Discussion -- Managing the Critically Ill Patient by Transplanting Best-of-Care Principles into Clinical Practice		Roxana Sulica, MD (moderator); James R. Klinger, MD; Ronald G. Pearl, PhD, MD; Fernando Torres, MD	31-35
Winter 2005	4	4	Profiles in PH Bertron M. Groves, MD: Visionary Builder of Bridges Between Cardiologists and Pulmonologists Through Hemodynamics			4
Spring 2006	5	1	Pulmonary Hypertension and Left Heart Disease			(Topic of Spring 2006 journal)	Ronald Oudiz, MD
Spring 2006	5	1	Diagnostic Dilemmas: Diastolic Heart Failure Causing Pulmonary Hypertension and Pulmonary Hypertension Causing Diastolic Dysfunction		Brian P. Shapiro, MD; Rick A. Nishimura, MD; Michael D. McGoon, MD; Margaret M. Redfield, MD	13-20
Spring 2006	5	1	Pulmonary Hypertension Out of Proportion to Left Heart Disease		Raymond L. Benza, MD; Jose A. Tallaj, MD	21-29
Spring 2006	5	1	Pulmonary Hypertension in Heart Failure Patients Who Are Referred for Cardiac Transplantation		Srinivas Murali, MD, FACC	30-35
Spring 2006	5	1	Roundtable Discussion -- Controversies and Consensus in PH With Left Heart Disease: Dosing Issues, Transplant Considerations, Wedge Pressure Targets, Postop Drug Selection, and More		James P. Maloney (moderator), MD; James B. Young, MD; Michael A. Mathier, MD; Robert P. Frantz, MD	36-40
Spring 2006	5	1	Profiles in PH Jack Reeves, MD, Remembered as 'Renaissance Ideal,' in Stellar Career Spanning Diverse Pulmonary Research			4, 29
Summer 2006	5	2	Pediatric Pulmonary Arterial Hypertension			(Topic of Spring 2006 journal)	Olivier Sitbon, MD; Robert Schilz, MD
Summer 2006	5	2	Management of Idiopathic PAH in Children: Reexamining the Evolving Treatment Algorithm		Erika Berman Rosenzweig, MD	13-21
Summer 2006	5	2	Persistant Pulmomonary Hypertension of the Newborn: Pathophysiology and Treatment		Steven H. Abman, MD	22-30
Summer 2006	5	2	A Classification System and Treatment Guidelines for PAH Associated with Congenital Heart Disease		Maurice Beghetti, MD	31-35
Summer 2006	5	2	Roundtable Discussion -- Identifying the Complex Spectrum of PAH and Selecting Candidates for Aggressive Treatment		Erika Berman Rosenzweig, MD (moderator); Steven H. Abman, MD; Dunbar Ivy, MD; Sheila G. Haworth, MD	36-42
Summer 2006	5	2	Profiles in PH Sheila G. Haworth, MD, Creator of the UK Network for the Care of Children with Pulmonary Hypertension, Reviews Milestones in Clinical Management			4-5
Autumn 2006	5	3	7th International PH Conference and Scientific Sessions			(Topic of Autumn 2006 journal)	Karen A. Fagan, MD; Raymond Benza, MD
Autumn 2006	5	3	Highlights From the 7th International PH Conference and Scientific Sessions			15-20
Autumn 2006	5	3	Award-Winning Abstracts Focus on Diagnostic Criteria, Impact of Calcium Channel Blockers			17
Autumn 2006	5	3	Genes and Pulmonary Hypertension: Update 2006			21-23
Autumn 2006	5	3	Inflammation in Pulmonary Hypertesion: How Immunobiology Provides the Missing Link Between These Conditions		Mark R. Nicolls, MD; Rasa Tamosiuniene, MD; Norbert Voelkel, MD	26-29
Autumn 2006	5	3	A Stepwise and Practical Approach to Optimizing Echocardiography in Pulmonary Hypertension		Derliz Mereles, MD; Ekkhard Grunig, MD	30-33
Autumn 2006	5	3	Roundtable Discussion -- New Perspectives on Inflammation, Genetics, Imaging, and Translational Research		Karen A. Fagan, MD (moderator); David B. Badesch, MD; C. Gregory Elliott, MD; Robert P. Frantz, MD	34-39
Autumn 2006	5	3	Profiles in PH Greg Elliott, MD, Exemplary Physician on a Mission to Promote Research Collaboration Between Patients and Investigators			4-5
Winter 2006	5	4	Emerging Therapies			(Topic of Winter 2006 journal)	Robert Frantz, MD; Murali Chakinala, MD
Winter 2006	5	4	Oral Therapies for PAH: State-of-the-Art and Investigational Approaches (PDF)		Michelle A. Beutz, MD, Todd M. Bull, MD, David B. Badesch, MD	13-17
Winter 2006	5	4	Combination Therapy for PAH: Current Rationale, Future Concepts (PDF)		Victor F. Tapson, MD	18-22
Winter 2006	5	4	Advances in Prostanoid Therapy: New Studies, New Methods of Delivery (PDF)		Marius M. Hoeper, MD	23-30
Winter 2006	5	4	Roundtable Discussion Recapping 5 Years, Exploring Emerging Approaches (PDF)		Vallerie V. McLaughlin, MD (moderator), Richard N. Channick, MD, Ivan M. Robbins, MD, Victor F. Tapson, MD	32-39
Winter 2006	5	4	Profiles in PH Victor Tapson, MD: Clinical Trialist, Role Model, and Mentor to the Next Generation of PH Specialists (PDF)			4-5
Spring 2007	6	1	Hemoglobinopathies and Pulmonary Hypertension			(Topic of Spring 2007 journal)	Roxana Sulica, MD
Spring 2007	5	3	Sickle Cell Disease-Associated Pulmonary Overview of Clinical Manifestations and EmergingHypertension: Therapeutic Options (PDF)		Roberto F. Machado, MD; Oswaldo Castro, MD	16-22
Spring 2007	5	3	Hemolysis-Associated Endothelial Dysfunction and Pulmonary Hypertension, an Emerging Cause of Death in the Hemoglobinopathies (PDF)		Mark T. Gladwin, MD; Gregory Kato, MD	23-30
Spring 2007	5	3	Pulmonary Hypertension in Thalassemia: Association with Hemolysis, Arginine Metabolism Dysregulation, and a Hypercoagulable State (PDF)		Claudia R. Morris, MD; Elliott P. Vichinsky, MD; Sylvia T. Singer, MD	31-38
Spring 2007	5	3	Roundtable Discussion Sickle Cell Disease and Pulmonary Hypertension: Addressing the Mixed Pathology and Special Considerations in Diagnosis and Treatment (PDF)		Harrison W. Farber, MD; Mark Gladwin, MD; Evelyn M. Horn, MD; Myung H. Park, MD	39-44
Spring 2007	5	3	Profiles in PH Gerald Simonneau, MD: Pioneer, Mentor, and a Driving Force in Pulmonary Hypertension Research for His Colleagues (PDF)			4-5
Summer 2007	6	2	Surgeries and PAH: Considerations, Guidelines, and Outcomes				Lead Editor: Srinivas Murali, MD Junior Editor: Ioana Preston, MD
Summer 2007	6	2	Pre-operative Risk Assessment of Pulmonary Arterial Hypertension Patients Undergoing General Surgery (PDF)		Dana McGlothin, MD; Teresa De Marco, MD	66-73
Summer 2007	6	2	Lung Transplantation for Pulmonary Arterial Hypertension (PDF)		Reda E. Girgis, MB, BCh; John V. Conte, MD; Jonathan B. Orens, MD	74-83
Summer 2007	6	2	Surgical Treatment of Chronic Thromboembolic Pulmonary Hypertension (PDF)		Michael M. Madani, MD; Stuart W. Jamieson, MB, FRCS	84-91
Summer 2007	6	2	Roundtable Discussion: Meeting the Challenge of Surgery and Pulmonary Hypertension: How to Manage the “Hemodynamic Environment” to Optimize Outcomes (PDF)		Richard Channick, MD; Kenneth R. McMurry, MD; Ronald Pearl, MD; Stuart Rich, MD	93-99
Summer 2007	6	2	Profiles in PH: Jane Morse, MD—A Physician-Investigator Whose “New Career” Gave Immeasurably to the Pulmonary Hypertension Community (PDF)			56-57
Autumn 2007	6	3	Pulmonary Arterial Hypertension in Adults with Congenital Heart Disease				Lead Editor: Erika Berman Rosenzweig, MD Junior Editor: Kristin Highland, MD
Autumn 2007	6	3	Pulmonary Arterial Hypertension In Adults With Congenital Heart Disease: General Overview of Disease Mechanisms (PDF)		Ingram Schulze-Neick, MD; John E. Deanfield, FRCP	121-125
Autumn 2007	6	3	Evaluating Operability in Adults with Congenital Heart Disease and the Role of Pretreatment with Targeted Pulmonary Arterial Hypertension Therapy (PDF)		Konstantinos Dimopoulos, MSc, MD; Michael A. Gatzoulis MD, PhD	126-135
Autumn 2007	6	3	Emerging Therapy of Congenital Heart Disease Associated with Pulmonary Hypertension (PDF)		Michael J. Landzberg, MD	136-141
Autumn 2007	6	3	Roundtable Discussion: Pulmonary Arterial Hypertension in Adults with Congenital Heart Disease (PDF)		Robyn Barst, MD; Jeffrey R. Fineman, MD; Michael A. Gatzoulis MD, PhD; ard A. Krasuski, MD	142-148
Autumn 2007	6	3	Profiles in PH: Joseph K. Perloff, MD: Father of Adult Congenital Heart Disease (PDF)			108
Winter 2007	6	4	Cases, Controversies and Conundrums			(Topic of Winter 2007 journal)	Lead Editor: Robert Schilz, DO, PhD
Winter 2007	6	4	Pulmonary Venous Hypertension: A Diagnostic and Therapeutic Dilemma (PDF)		Francisco Soto, MD (comment by Vallerie V. McLaughlin, MD)	168-175
Winter 2007	6	4	The Vasoreactive Patient:Diagnosis, Treatment, and Follow-up (PDF)		Charles D. Burger, MD; Srinivas Murali, MD	176-179
Winter 2007	6	4	Chronic Thromboembolic Disease: Underdiagnosis and Nonsurgical Options (PDF)		Robert Schilz, DO, PhD; William Auger, MD	182-185
Winter 2007	6	4	Roundtable Discussion A Case of Catastrophic Antiphospholipid Syndrome (PDF)		An Electronic Roundtable Discussion from the Pulmonary Hypertension Clinicians and Researchers	190-194
Winter 2007	6	4	Profiles in PH Sir Magdi Yacoub: Surgeon, Knight, and “King of Hearts” (PDF)			160-161
Spring 2008	7	1	Unlocking New Treatment Benefits and Options in PAH			(Topic of Spring 2008 journal)	Lead Editors: James Maloney, MD; Todd Bull, MD
Spring 2008	7	1	Evidence-based Medical Management of Pulmonary Hypertension 2008: Review of Updated 2007 ACCP Guidelines (PDF)		Jeremiah P. Depta, MD; Richard A. Krasuski, MD	222-227
Spring 2008	7	1	Phase 2 and 3 Clinical Trials in Pulmonary Arterial Hypertension (PDF)		Zeenat Safdar, MD	228-234
Spring 2008	7	1	Combination Therapies in Pulmonary Arterial Hypertension (PDF)		Ioana R. Preston, MD	235-242
Spring 2008	7	1	SPECIAL SECTION: Guidelines for the Prevention of Central Venous Catheter-Related Bloodstream Infections with Prostanoid Therapy for Pulmonary Arterial Hypertension (PDF)		Aimee K. Doran, MS, RN, CPNP; D. Dunbar Ivy, MD; Robyn J. Barst, MD; Nicholas Hill, MD; Srinivas Murali, MD; Raymond L. Benza, MD; and the Scientific Leadership Council of PHA	245-248
Spring 2008	7	1	Roundtable Discussion Expanded Use of PAH Medications (PDF)		Karen A. Fagan, MD (moderator); Kamal K. Mubarak, MD; Zeenat Safdar, MD; Aaron Waxman, MD, PhD; Roham T. Zamanian, MD	249-254
Spring 2008	7	1	Profiles in PH David Badesch, MD, Outstanding Researcher, but First to Credit Team of Clinicians and Caregivers (PDF)			208-209
Spring 2008	7	1	Internation Corner Comments on Q4 by Adam Torbicki, MD, PhD (Poland) (PDF)			217
Summer 2008	7	2	Pulmonary Hypertension in Connective Tissue Disease			(Topic of Summer 2008 journal)	Lead Editors: Ronald J. Oudiz, MD; Karen A. Fagan, MD
Summer 2008	7	2	Profiles in Pulmonary Hypertension: Virginia D. Steen, MD: Pushing the Envelope of Research, Redefining the Link Between Scleroderma and PAH (PDF)		Virginia D. Steen, MD	264
Summer 2008	7	2	Pulmonary Hypertension in Systemic Lupus Erythematosus (PDF)		Kristin B. Highland, MD, MSCR and Gary Gilkeson, MD	280
Summer 2008	7	2	Pulmonary Hypertension and the Antiphospholipid Syndrome (PDF)		Raj S. Kasthuri, MD and Robert A. S. Roubey, MD	286
Summer 2008	7	2	Scleroderma Associated Pulmonary Hypertension (PDF)		Victoria K. Shanmugam, MD and Virginia D. Steen, MD	292
Summer 2008	7	2	Roundtable Discussion Pulmonary Arterial Hypertension Associated With Scleroderma (PDF)		Moderated by Harrison (Hap) Farber, MD, Panel members included Richard M. Silver, MD, Virginia D. Steen, MD, Charles Strange, MD	301
Summer 2008	7	2	SPECIAL SECTION: The 4th World Symposium on Pulmonary Hypertension (PDF)			307
Summer 2008	7	2	International Corner: Combination Therapy in Pulmonary Artery Hypertension (PDF)		Nicholas W. Morrell, MA, MD, FRCP	277
Autumn 2008	7	3	Highlights From Scientific Sessions of PHA’s International Conference			(Topic of Autumn 2008 journal)
Autumn 2008	7	3	Profiles in Pulmonary Hypertension: In a Remarkably Short Time, Vallerie McLaughlin, MD, Joins a Select Group of Investigators Blazing a Trail in PH Research (PDF)		Vallerie V. McLaughlin, MD	320
Autumn 2008	7	3	Building Medical Education in PH: A Partnership Initiative to Advance Medical Understanding of Pulmonary Hypertension (PDF)			322
Autumn 2008	7	3	Advances in Pulmonary Hypertension CME Section (PDF)			330
Autumn 2008	7	3	The Metabolic Syndrome and Cardiac Function (PDF)		Heiko Bugger, MD, PhD and E. Dale Abel, MD, PhD	332
Autumn 2008	7	3	Specialized Centers of Clinically Oriented Research Programs in Pulmonary Hypertension Reported Progress at the PHA Scientific Sessions (PDF)		Karen A. Fagan, MD,	337
Autumn 2008	7	3	Specialized Center in Clinical Oriented Research (SCCOR) Update: Mechanisms and Treatment of Lung Vascular Disease in Infants and Children (PDF)		Kurt Stenmark, MD	341
Autumn 2008	7	3	Getting More From Right Heart Catheterization: A Focus on the Right Ventricle (PDF)		Hunter C. Champion, MD, PhD	343
Autumn 2008	7	3	Animal Models of Human Severe PAH (PDF)		Ivan F. McMurtry, PhD	346
Autumn 2008	7	3	International Corner: Connective Tissue Disease-Associated Pulmonary Hypertension (PDF)		Christopher P. Denton PhD, FRCP	350
Autumn 2008	7	3	Self-Assessment Examination (PDF)			351
Autumn 2008	7	3	Pulmonary Hypertension Roundtable: PHA Scientific Sessions Provide a Great Window Into Treatment Breakthroughs While Inspiring Physicians and Patients Alike (PDF)		Karen Fagan, MD; Todd Bull, MD; Ivan F. McMurtry, PhD; Omar A. Minai, MD	353
Winter 2008-09	7	4	New Applications of Diagnostic Modalities			(Topic of Winter 2008-09 journal)
Winter 2008-09	7	4	Profiles in Pulmonary Hypertension: John Newman, MD (PDF)		John Newman, MD
Winter 2008-09	7	4	The Role of Echocardiography in the Diagnosis and Assessment of PH (PDF)		Stephen C. Mathai, MD, MHS and Paul M. Hassoun, MD	379
Winter 2008-09	7	4	Cardiopulmonary Hemodynamics in PH: Pressure Tracings, Waveforms, and More (PDF)		Francisco J. Soto, MD, MS and James F. Kleczka, MD	386
Winter 2008-09	7	4	Role of Cardiac MRI in Pulmonary Hypertension (PDF)		Ravi Desai, MD, Fernando Torres, MD, Himanshu Gupta, MD	396
Winter 2008-09	7	4	CME Self-Assessment Examination (PDF)			403
Winter 2008-09	7	4	Ambulatory Hemodynamic Monitoring in Pulmonary Arterial Hypertension (PDF)		Robert P. Frantz, MD, Barbro Kjellstrom, PhD, Michael McGoon, MD	405
Winter 2008-09	7	4	Pulmonary Hypertension Roundtable (PDF)		Ronald J. Oudiz, MD, Hunter C. Champion, MD, PhD, Robert Naeije, MD, PhD,Virginia D. Steen, MD, David Systrom, MD,	412
Winter 2008-09	7	4	International Corner (PDF)		Julio Sandoval, MD	417
Spring 2009	8	1	New Therapeutic Approaches in PAH				R. James White, MD, PhD
Spring 2009	8	1	Advances in Pulmonary Hypertension CME Section (PDF)		15-16
Spring 2009	8	1	Near-Term Novel Therapies for PAH (PDF)		David Langleben, MD	17-20
Spring 2009	8	1	Evaluating Recent Therapeutic Trials in Pulmonary Arterial Hypertension: Raising the Bar for Clinical Investigation (PDF)		Murali Chakinala, MD, FCCP	24-31
Spring 2009	8	1	Update on the Development of Oral Prostacyclin Analogs for the Treatment of PAH (PDF)		R. James White, MD, PhD	32-36
Spring 2009	8	1	CME Self-Assessment Examination (PDF)			37-38
Spring 2009	8	1	Pulmonary Hypertension Roundtable: Ethical Considerations for RCTs in PAH (PDF)		Scott Halpern, MD, PhD, MBE; David B. Badesch, MD; Michael D. McGoon, MD; Myung Park, MD	42-46
Spring 2009	8	1	International Corner: A Meeting of Minds From Around the World (PDF)		Anne Keogh, MBBS, PhD	47

 

Patients | Medical Professionals | Caregivers | Media

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs. Questions about the site? email pha@PHAssociation.org Pulmonary Hypertension Association 801 Roeder Road, Ste. 400 Silver Spring, MD 20910 Copyright © 2009 Pulmonary Hypertension Association Read our privacy policy.

For optimal viewing of PHAssociation.org we recommend the following:

PC : Windows running Internet Explorer 5.5 or higher Macintosh: Internet Explorer 5.2 or higher free download from Microsoft.com   Adobe Flash Player free download from Adobe.com   Adobe Acrobat Reader 6.0 or higher free download from Adobe.com